Is TB-500 Legal in Tennessee?

HealthRX.com

This peptide has no FDA approval and no lawful compounding path yet

Print or save as PDF

See the public record for TB-500

  • What it is / A synthetic 7-amino-acid fragment of thymosin beta-4, not the full protein [1]
  • FDA approval / No FDA-approved drug contains it [1]
  • FDA compounding lists / Not on FDA's bulks list and in none of the interim-policy categories [2][3][8]
  • FDA safety-risk page / In the 'nominated but withdrawn' table, not the active category 2 table [6]
  • HHS policy / Draft enforcement discretion for TB-500 acetate injections, filed October 2026 [4][5]
  • Tennessee / State-licensed pharmacies and physicians that compound must meet the federal conditions [3]
  • Sport / Prohibited at all times under WADA S2.3 [7]

What TB-500 is

A synthetic 7-amino-acid, N-acetylated fragment of the 43-amino-acid protein thymosin beta-4, covering residues 17 to 23, with a molecular weight of about 889 g/mol. 'TB-500' is a common name, not an official drug name, and FDA found several salts and derivatives, including different active moieties, sold under it [1].

Is TB-500 approved, or on FDA's compounding lists?

No. FDA's July 2026 review found no USP or National Formulary monograph for TB-500, no FDA-approved drug containing it, no listing in the European or Japanese pharmacopeias, and no approved product in Canada, Australia, the UK or several European countries, or authorized by the European Medicines Agency [1]. A bulk substance can be used in state-licensed compounding only if it complies with a USP or NF monograph, is a component of an FDA-approved drug, or appears on FDA's list of bulk substances that can be used in compounding [3]. TB-500 meets none of those conditions. It appears in none of the three categories of FDA's interim policy for state-licensed pharmacies and physicians (updated May 14, 2026) or of the outsourcing facility version (updated March 21, 2025), so the category 1 policy of generally not acting against compounders does not cover it [8][2][3].

On FDA's page about bulk substances that may present significant safety risks, 'Thymosin beta-4, fragment (LKKTETQ), also known as TB-500' sits in the 'nominated but withdrawn' table, and removal from category 2 was not a finding that it is safe [6]. In July 2026 FDA staff proposed that neither the free base nor the acetate be added to the compounding list, citing poor characterization, no human data, no evidence of effectiveness for the wound-healing use FDA evaluated, immunogenicity risk, and existing FDA-approved wound treatments [1]. FDA's Pharmacy Compounding Advisory Committee voted in favor of adding it; that vote is advice only and not binding, and listing takes formal rulemaking [9][4].

The HHS draft policy

HHS filed a draft enforcement-discretion policy on October 28, 2026, Federal Register document 2026-22192, with publication scheduled for October 30, 2026 and comments due two weeks after publication. It names TB-500 among six peptides and covers TB-500 acetate given by subcutaneous or intramuscular injection [4][5]. HHS says it 'does not intend to take enforcement action' against a state-licensed pharmacy, federal facility or licensed physician compounding with it when the conditions are met, such as a single active ingredient, a patient-specific prescription, a manufacturer registered with FDA with a certificate of analysis, and a label reading 'This is a compounded drug product. Not for resale.' [4][5] The notice states the policy 'does not establish any rights for any person and is not binding on HHS or the public,' and HHS may revisit it, for example if a safety signal or product quality issue arises [4].

What this means for Tennessee

Federal status is what applies to Tennessee pharmacies and physicians who compound: they must meet the federal conditions described above, and TB-500 has no FDA approval and no place on FDA's bulks list [3][1]. The HHS policy for certain TB-500 acetate injections remains a draft [4].

FDA found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one, and found it sold online as a 'research use only' injectable powder in 2 mg to 15 mg vials, alone or blended with BPC-157 [1].

Athletes: WADA's Prohibited List names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3, prohibited at all times in and out of competition, and it appears on both the 2026 and 2027 Lists [7][10].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. According to the article, what must a bulk substance meet to be used in state-licensed compounding?

Question 1 of 4

Score: 0 right, 0 of 4 answered

What people on Reddit report

Pharmacy and patient accounts from a Reddit thread on the FDA advisory vote, about whether these peptides can legally be compounded now and how state boards handle it.

Rockinvestor · NTNPerformance

The majority, such as all the ones being reviewed by the committee are currently on the do not compound list.

A compounding pharmacy owner says the peptides under committee review are currently on the do not compound list.

Read the source discussion

strange_waters · NTNPerformance

I thought that currently, most of these were technically "legal" to compound, just not formally approved. I go to a wellness clinic that specializes in peptides and the doctor actually prescribes them to be compounded in a verified 503a Pharmacy.

A patient says their clinic prescribes peptides to be compounded by a pharmacy and believed this was a grey area.

Read the source discussion

Questions worth asking

Choose the questions you want to keep

Is TB-500 legal in Tennessee?
TB-500 is not FDA-approved and is not on FDA's list of bulk substances for compounding [1][2][3]. HHS's draft policy describing conditional enforcement discretion for certain TB-500 acetate injections is non-binding, does not approve TB-500 and does not add it to FDA's lists [4][5].
Can a Tennessee pharmacy compound TB-500 for a patient?
TB-500 is not on FDA's list of bulk substances for state-licensed compounding, not on the outsourcing facility list, and not covered by the category 1 interim policy [8][2][3]. A separate, non-binding HHS draft says it does not intend to take enforcement action for certain TB-500 acetate injections when its conditions are met [4][5]. FDA found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one [1].
Is TB-500 still on FDA's category 2 safety-risk list?
It appears in the 'nominated but withdrawn' table, which holds substances previously in category 2 whose nominators withdrew them, not in the active category 2 table. Removal was not a finding that it is safe, and FDA still describes missing human exposure data and immunogenicity risk for injectable peptides [6].
Has TB-500 ever been given to a person in a study?
FDA's July 2026 review searched PubMed, Embase and ClinicalTrials.gov and found no article in which TB-500 was given to a human, and none of the three papers the nominator cited involved TB-500 in humans [1].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

Can you buy TB-500 over the counter?

No FDA-approved product contains TB-500, so there is no approved over-the-counter version. FDA found it sold online as a 'research use only' injectable powder in 2 mg to 15 mg vials, alone or blended with BPC-157. That labeling does not make it a lawful drug, and FDA policy does not make it a lawful compounded drug in Tennessee or anywhere else in the US.

Is TB-500 FDA approved?

No. TB-500 is not an FDA-approved drug, and no FDA-approved drug contains it. FDA's July 2026 review found no USP or National Formulary monograph for it and no approved product in Canada, Australia, the UK or several European countries. It is also not on FDA's list of bulk substances that can be used in compounding.

Show all 11 referencesHide references
Evidence overview for Is TB-500 Legal in Tennessee?